DoW Arthritis Clinical Research Award

Status

Closed

Agency

Defense · DOD-AMRAA

Notice

HT942526ATRPCRA

Type

Grant / cooperative agreement

Value

Total program funding: $7,150,000

Deadline

Oct 22, 2026 · confirm cutoff time in notice

Eligibility

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

From the official notice

Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research that evaluates disease-specific factors and interventions. Research is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing any and all types of arthritis is encouraged. Applications must address one of two FY26 ATRP CRA Focus Areas: Prevention and Early Diagnosis, or Treatment and Mitigation of Disease Progression/Burden. Distinctive Features: The FY26 ATRP CRA offers funding for two research levels. It is the responsibility of the applicant to select the level that aligns with the scope of the proposed research. • Research Level 1: Applications proposing clinical research or early-phase/pilot clinical trials, to include new or emerging research that is not ready for…

Source and next steps

Read the official notice and response instructions

This is a sourced opportunity notice. The summary is an excerpt from the issuing agency; amounts and eligibility are taken from its structured record. Check the full notice, amendments and submission requirements before responding.

Source observed 2026-10-16 Eastern. Browse opportunities